Literature DB >> 25084753

Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.

Ugur Uygunoglu1, Aysegul Gunduz, Sukriye F Menku, Basak Yilmaz, Esra Hatipoglu, Cengiz Yalcinkaya, Sabahattin Saip, Hulya Apaydin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25084753     DOI： 10.1007/s12311-014-0587-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN： 1473-4222            Impact factor:   3.847


× No keyword cloud information.
  16 in total

1.  Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation : six-year MRI follow-up.

Authors:  Andrea Mignarri; Maria Teresa Dotti; Marina Del Puppo; Gian Nicola Gallus; Antonio Giorgio; Alfonso Cerase; Lucia Monti
Journal:  Neuroradiology       Date:  2012-03-15       Impact factor: 2.804

2.  High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.

Authors:  Melih Vural; Sibel Ozekmekçi; Hülya Apaydin; Attila Altinel
Journal:  Mov Disord       Date:  2003-04       Impact factor: 10.338

3.  Suppression of myoclonus in SCA2 by piracetam.

Authors:  Anna De Rosa; Pasquale Striano; Fabrizio Barbieri; Arturo de Falco; Carlo Rinaldi; Tecla Tucci; Salvatore Striano; Alessandro Filla; Giuseppe De Michele
Journal:  Mov Disord       Date:  2006-01       Impact factor: 10.338

4.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

5.  Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.

Authors:  G Salen; V Berginer; V Shore; I Horak; E Horak; G S Tint; S Shefer
Journal:  N Engl J Med       Date:  1987-05-14       Impact factor: 91.245

6.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

7.  Levetiracetam improves intention tremor in fragile x-associated tremor/ataxia syndrome.

Authors:  Riccardo Saponara; Salvatore Greco; Giuliana Proto; Teresa Trubia; Elisabetta Domina
Journal:  Clin Neuropharmacol       Date:  2009 Jan-Feb       Impact factor: 1.592

Review 8.  Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.

Authors:  Mohammed H Moghadasian
Journal:  Clin Invest Med       Date:  2004-02       Impact factor: 0.825

9.  The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.

Authors:  D Ince Gunal; K Agan; N Afsar; D Borucu; O Us
Journal:  J Clin Pharm Ther       Date:  2008-04       Impact factor: 2.512
View more
  1 in total

Review 1.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.